The value of transcranial Doppler derived pulsatility index for diagnosing cerebral small-vessel disease

Abbas Ghorbani, Mohammad Javad Ahmadi, Hamidreza Shemshaki, Abbas Ghorbani, Mohammad Javad Ahmadi, Hamidreza Shemshaki

Abstract

Background: The pulsatility index (PI), measured by transcranial Doppler (TCD) ultrasonography, can reflect vascular resistance induced by cerebral small-vessel disease (SVD). We evaluated the value of TCD-derived PI for diagnosing SVD as compared with magnetic resonance imaging (MRI).

Materials and methods: Fifty-six consecutive cases with SVD (based on MRI) and 48 controls with normal MRI underwent TCD. Based on MRI findings, patients were categorized into five subgroups of preventricular hyperintensity (PVH), deep white matter hyperintensity (DWMH), lacunar, pontin hyperintensity (PH), and PVH+DWMH+lacunar. The sensitivity and specificity of TCD in best PI cut-off points were calculated in each group.

Results: The sensitivity and specificity of TCD in comparison with MRI with best PI cut-off points were as follows: In PVH with PI = 0.83, the sensitivity and specificity was 90% and 98%, respectively. In DWMH with PI = 0.79, the sensitivity and specificity was 75% and 87.5%, respectively. In lacunar with PI = 0.80, the sensitivity and specificity was 73% and 90%, respectively. In PH with PI = 0.69, the sensitivity and specificity was 92% and 87.5%, respectively. And, in PVH+DWMH+lacunar subgroup with PI = 0.83, the sensitivity and specificity was 90% and 96%, respectively.

Conclusions: Increased TCD derived PI can accurately indicate the SVD. Hence, TCD can be used as a non-invasive and inexpensive method for diagnosing SVD, and TCD-derived PI can be considered as a physiologic index of the disease as well.

Keywords: Cerebral small-vessel disease; diagnosis; pulsatility index; small-vessel disease; transcranial Doppler ultrasonography; vascular resistance.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. Cerebrovasc Dis. 2009;27:493–501.
    1. Mok VC, Lau AY, Wong A, Lam WW, Chan A, Leung H, et al. Long-term prognosis of Chinese patients with a lacunar infarct associated with small vessel disease: A five-year longitudinal study. Int J Stroke. 2009;4:81–8.
    1. Conijn MM, Kloppenborg RP, Algra A, Mali WP, Kappelle LJ, Vincken KL, et al. Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: The Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study. Stroke. 2011;42:3105–9.
    1. Patel B, Markus HS. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke. 2011;6:47–59.
    1. Kidwell CS, el-Saden S, Livshits Z, Martin NA, Glenn TC, Saver JL. Transcranial Doppler pulsatility indices as a measure of diffuse small-vessel disease. J Neuroimaging. 2001;11:229–35.
    1. Gosling RG, King DH. Arterial assessment by Doppler-shift ultrasound. Proc R Soc Med. 1974;67:447–9.
    1. Michel E, Zernikow B. Gosling's Doppler pulsatility index revisited. Ultrasound Med Biol. 1998;24:597–9.
    1. Mok V, Ding D, Fu J, Xiong Y, Chu WW, Wang D, et al. Transcranial Doppler ultrasound for screening cerebral small vessel disease: A community study. Stroke. 2012;43:2791–3.
    1. Heliopoulos I, Artemis D, Vadikolias K, Tripsianis G, Piperidou C, Tsivgoulis G. Association of ultrasonographic parameters with subclinical white-matter hyperintensities in hypertensive patients. Cardiovasc Psychiatry Neurol 2012. 2012 616572.
    1. Fisher CM. Lacunar strokes and infarcts: A review. Neurology. 1982;32:871–6.
    1. Pullicino P, Ostrow P, Miller L, Snyder W, Munschauer F. Pontine ischemic rarefaction. Ann Neurol. 1995;37:460–6.
    1. Faraci FM. Protecting against vascular disease in brain. Am J Physiol Heart Circ Physiol. 2011;300:H1566–82.
    1. Harper SL, Bohlen HG, Rubin MJ. Arterial and microvascular contributions to cerebral cortical autoregulation in rats. Am J Physiol. 1984;246:H17–24.
    1. Cho SJ, Sohn YH, Kim GW, Kim JS. Blood flow velocity changes in the middle cerebral artery as an index of the chronicity of hypertension. J Neurol Sci. 1997;150:77–80.
    1. Lee KY, Sohn YH, Baik JS, Kim GW, Kim JS. Arterial pulsatility as an index of cerebral microangiopathy in diabetes. Stroke. 2000;31:1111–5.
    1. Titianova EB, Velcheva IV, Mateev PS. Effects of aging and hematocrit on cerebral blood flow velocity in patients with unilateral cerebral infarctions: A Doppler ultrasound evaluation. Angiology. 1993;44:100–6.
    1. Foerstl H, Biedert S, Hewer W. Multiinfarct and Alzheimer-type dementia investigated by transcranial Doppler sonography. Biol Psychiatry. 1989;26:590–4.
    1. Bakker SL, de Leeuw FE, de Groot JC, Hofman A, Koudstaal PJ, Breteler MM. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology. 1999;52:578–83.
    1. Molina C, Sabín JA, Montaner J, Rovira A, Abilleira S, Codina A. Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: A case-control study. Stroke. 1999;30:2296–301.
    1. Panczel G, Bönöczk P, Voko Z, Spiegel D, Nagy Z. Impaired vasoreactivity of the basilar artery system in patients with brainstem lacunar infarcts. Cerebrovasc Dis. 1999;9:218–23.
    1. Puls I, Hauck K, Demuth K, Horowski A, Schliesser M, Dörfler P, et al. Diagnostic impact of cerebral transit time in the identification of microangiopathy in dementia: A transcranial ultrasound study. Stroke. 1999;30:2291–5.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera